logo

For the Inventor, By the Inventor

Santa Clara, CA, United States of America

Ramakrishnan Chidambaram

This inventor holds 7 USPTO granted patents and 3 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Karo Bio Ab. Active years: 2004-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramakrishnan Chidambaram. Retrieved from https://idiyas.com/inventor/ramakrishnan-chidambaram

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 71.4

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 112(Granted Patents)


Location History:

  • Pennington, NJ (US) (2004 - 2011)
  • Santa Clara, CA (US) (2011 - 2014)

Company Filing History:

goldMedal7 out of 3,737 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal1 out of 34 
 
Karo Bio Ab
 patents
where one patent can have more than one assignee

Years Active: 2004-2014

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 8680103 - Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors (2014-03-25),
2. 8242270 - Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors (2012-08-14),
3. 7968718 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2011-06-28),
4. 7956214 - Process for the preparation of aniline-derived thyroid receptor ligands (2011-06-07),
5. 7601715 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2009-10-13),
6. 7491725 - Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors (2009-02-17),
7. 6806381 - Process for the preparation of aniline-derived thyroid receptor ligands (2004-10-19),

Title: Ramakrishnan Chidambaram: Innovator in Pharmaceutical Chemistry

Introduction

Ramakrishnan Chidambaram is a notable inventor based in Santa Clara, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work primarily focuses on developing innovative compounds that serve as kinase inhibitors, which are crucial in the treatment of various diseases.

Latest Patents

Among his latest patents is a process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors. This invention relates to a pharmaceutical composition of a crystalline monohydrate of the compound characterized by specific unit cell parameters. Another patent also involves processes for preparing compounds with the same formula, showcasing his dedication to advancing pharmaceutical science.

Career Highlights

Throughout his career, Ramakrishnan has worked with prominent companies such as Bristol-Myers Squibb Company and Karo Bio AB. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Ramakrishnan has collaborated with esteemed colleagues, including Jean Lajeunesse and John D DiMarco. These partnerships have further enriched his research and innovation in the pharmaceutical sector.

Conclusion

Ramakrishnan Chidambaram's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of effective treatments for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…